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ABSTRACT In our previous work, using a fluorescent
adenosine-A3 receptor (A3AR) agonist and fluorescence
correlation spectroscopy (FCS), we demonstrated high-
affinity labeling of the active receptor (R*) conforma-
tion. In the current study, we used a fluorescent A3AR
antagonist (CA200645) to study the binding character-
istics of antagonist-occupied inactive receptor (R) con-
formations in membrane microdomains of individual
cells. FCS analysis of CA200645-occupied A3ARs re-
vealed 2 species, D2 and D3, that diffused at 2.29 
0.35 and 0.09  0.03 m2/s, respectively. FCS analysis
of a green fluorescent protein (GFP)-tagged A3AR
exhibited a single diffusing species (0.105 m2/s). The
binding of CA200645 to D3 was antagonized by nano-
molar concentrations of the A3 antagonist MRS 1220,
but not by the agonist NECA (up to 300 nM), consistent
with labeling of R. CA200645 normally dissociated
slowly from the A3AR, but inclusion of xanthine amine
congener (XAC) or VUF 5455 during washout markedly
accelerated the reduction in the number of particles
exhibiting D3 characteristics. It is notable that this
effect was accompanied by a significant increase in the
number of particles with D2 diffusion. These data
show that FCS analysis of ligand-occupied receptors
provides a unique means of monitoring ligand A3AR
residence times that are significantly reduced as a
consequence of allosteric interaction across the dimer
interface.—Corriden, R., Kilpatrick, L. E., Kellam, B.,
Briddon, S. J., Hill, S. J. Kinetic analysis of antagonist-
occupied adenosine-A3 receptors within membrane mi-
crodomains of individual cells provides evidence for
receptor dimerization and allosterism. FASEB J. 28,
4211–4222 (2014). www.fasebj.org
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The adenosine-A3 receptor (A3AR) is a G-protein-
coupled receptor (GPCR) and the most recently iden-
tified subtype of the adenosine receptor family (1). It is
widely distributed throughout the body and has been
proposed as a target for therapeutic intervention in
several diseases, including inflammation, glaucoma,
and cancer (2–7). More recently, this receptor has been
shown to be expressed in a highly localized manner in
human neutrophils and may play an important role in
the control of infection (8). In these cells, the A3AR is
concentrated at the leading edge during chemotaxis,
where it promotes cell migration (9, 10) and the
formation of filopodia-like projections that can scav-
enge pathogens (8).
Discrete organization of GPCRs, such as the A3AR, in
membrane compartments and microdomains is becom-
ing increasingly evident (11–14). This spatial segrega-
tion provides a mechanism by which intracellular sig-
naling can be orchestrated within a cell in a manner
dependent on the signaling proteins resident within
the specific membrane domains containing the recep-
tor. This mechanism may also lead to a signaling bias,
whereby specific agonists can direct signaling to either
classic G-protein-coupled signaling pathways or to G
protein-independent pathways (e.g., -arrestin) via the
same receptor (15–18) and may be a consequence of
ligands interacting in different ways with the key ele-
ments of the protein responsible for receptor activation
(19, 20). However, biased signaling may also be an
extension of the concept of allosterism (2, 17, 21, 22),
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whereby a signaling protein (i.e., G protein or -arres-
tin) can bind to a GPCR at a site distinct from the
orthosteric ligand-binding site for the natural agonist
(in this case, adenosine) and produce a conformational
change. This allosteric effect may also alter the efficacy
or affinity of a ligand’s binding to the orthosteric site in
a probe-dependent manner (2, 17, 21, 22).
Fluorescent ligands for several GPCRs (23–27) have
been successfully used to produce evidence of alloster-
ism at the single-cell level (28–30). These studies have
shown that allosteric ligands and negative cooperativity
across A3AR homodimers can produce marked changes
in the dissociation kinetics of fluorescent ligands from
the orthosteric site of the receptor (28–30). Fluores-
cence correlation spectroscopy (FCS) is a quantitative
biophysical technique that can be used to quantify both
the diffusional characteristics and number of fluores-
cent ligand-occupied receptor complexes within a
highly localized membrane microdomain (0.2 m2;
ref. 29). Fluorescent ligands, in combination with FCS,
have also been used to study the properties and behav-
ior of adenosine receptors in discrete membrane mi-
crodomains of living cells (14, 23, 32–34).
Previous FCS work with a fluorescent A3AR agonist
revealed 2 populations of agonist-occupied A3AR com-
plexes with apparently different diffusion coefficients
and molecular sizes (diffusion coefficients of 2.7 and
0.12 m2/s; ref. 14). Competition studies with an
antagonist (MRS 1220) and agonist (NECA) indicated
that the slower diffusing component had high (low
nanomolar) affinity for both agonists and antagonists.
This finding suggests that the use of very low concen-
trations of fluorescent agonist in that study allowed
selective labeling of an active receptor (R*) conforma-
tion of the A3AR (14). Furthermore, the lack of effect
of pertussis toxin on this high-affinity agonist binding
suggested that the agonist-occupied receptor detected
was not coupled to Gi proteins (14). Unfortunately, the
amount of the faster component labeled by the fluores-
cent agonist was too low for detailed analysis, although
it was speculated that it might represent the inactive
receptor (R) conformation, which normally has low
affinity for agonists (14).
To further clarify this question, in the current study
we used FCS to investigate the diffusional characteris-
tics of antagonist–A3AR complexes in membrane do-
mains by using the fluorescent antagonist CA200645
(27), which should have a high affinity for R. We used
this approach to investigate the nature of the faster
diffusing species that was detected in a prior study with
a fluorescent agonist (14). We also provide evidence
that simultaneous monitoring of the 2 diffusing species
detected with a fluorescent antagonist can yield insights
into receptor allosterism, ligand residence time, and
dimerization in small membrane microdomains.
MATERIALS AND METHODS
Materials
MRS 1220 was obtained from Tocris Cookson (Avonmounth,
UK). CA200645 and ABEA-X-BY630 were obtained from
CellAura Technologies (Nottingham, UK). VUF 5455 was
synthesized by B. Kellam (Centre for Biomolecular Sciences,
School of Pharmacy, University of Nottingham, Nottingham,
UK). Fetal calf serum was obtained from PAA Laboratories
(Yeovil, UK). All other reagents, including xanthine amine
congener (XAC), were obtained from Sigma-Aldrich Inc.
(Poole, UK).
Cell culture
CHO-K1 cells stably expressing either the human A3AR
(CHO-A3 cells; ref. 14) or an A3AR–green fluorescent protein
(GFP) fusion protein (CHO-A3GFP cells) were used. The
CHO-A3 GFP cell line was generated by transfecting CHO-K1
cells with a pcDNA3.1 plasmid containing cDNA encoding
the full-length human A3AR fused in frame with GFP by using
Lipofectamine (Life Technologies, Paisley, UK) according to
the manufacturer’s instructions. The transfected cells were
subjected to selective pressure for 2–3 wk by the addition of 1
mg/ml G418 to the normal growth medium to generate a
stable, mixed-population cell line. For confocal and FCS
analysis, the cells were grown in phenol red–free Dulbecco’s
modified Eagle’s medium/Ham’s F-12 (DMEM-F12) contain-
ing 10% fetal calf serum and 2 mM glutamine and incubated
under the same conditions; 48 h before experimentation, the
cells were seeded in Nunc Labtek 8-well plates (Fisher Scien-
tific, Loughborough, UK). Before the analysis, the cells were
washed twice with HEPES-buffered saline solution (HBSS; ref.
23), which also served as the incubation medium in the
experiments.
Confocal imaging
Live-cell imaging was performed with CHO-A3 or CHO-A3-
GFP cells grown in Nunc Labtek 8-well plates and maintained
as described above. For the ligand-binding experiments, the
cells were incubated with the required concentration of
fluorescent ligand for 10 min at 37°C before imaging. Bind-
ing specificity was assessed by preincubating cells with the
nonfluorescent A3AR antagonist MRS 1220 (100 nM) for 30
min at 37°C before the addition of CA200645. Images were
captured with a Zeiss LSM710META confocal microscope
(Zeiss, GmbH, Jena, Germany) fitted with a Plan-Apochromat
63, 1.40 NA, DIC, oil-immersion objective (Zeiss). A 488 nm
argon laser was used to excite the GFP, and a 633 nm HeNe
laser was used to excite the BODIPY 630/650-labeled
CA200645. A variable spectral detection system was used to
capture emission at 480–530 and 645–680 nm for GFP and
CA200645, respectively. Images within each set of experi-
ments were collected by using identical settings for pinhole
diameter, laser power, detector gain, and offset.
FCS
On the day of experimentation, CHO-A3 cells were washed
twice in HBSS before further incubation in the presence or
absence of MRS 1220 (0.3–300 nM; 20 min at 37°C) or the
nonselective adenosine receptor agonist NECA (0.3–300 nM;
10 min at 24°C) . Cells were allowed to equilibrate to 22°C
and were then exposed to 1, 2.5, 5, or 10 nM CA200645 for 10
min. FCS measurements were then taken on the upper
membrane of individual cells with a Confocor2 fluorescence
correlation spectrometer (Zeiss) with a c-Apochromat 40,
1.2 NA, water-immersion objective, as described elsewhere
(23). Briefly, the detection volume was localized in the x–y
plane over the cell nucleus, with a live transmitted light
image, and subsequently in the z plane, with an intensity scan.
For FCS measurements with fluorescently labeled ligands,
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fluorescence fluctuations were recorded for two 30 s intervals
at a laser power of 0.3 kW/cm2 following a 10 s prebleaching
step at a laser power of 0.2 kW/cm2. For measurements using
GFP-tagged receptors, fluorescence fluctuations were re-
corded for two 30 s intervals at a laser power of 0.15 kW/cm2
following a 10 s prebleaching at 0.05 kW/cm2. FCS measure-
ments of CA200645 in solution were also made, to determine
the diffusion coefficient of free ligand (9 times for 10 s each,
0.15 kW/cm2). Fluorescence fluctuations were evaluated with
standard autocorrelation analysis within the Zeiss AIM 4.2
software.
The autocorrelation function G()for fluctuations around
a mean intensity I is described as follows, with the angle
brackets representing an ensemble average:
G  1 
I(t) · I(t  ) 
 I2 
Here, the intensity fluctuation I(t) around the average
intensity I, at time t, is correlated with the fluctuation at a
given time later, I(t). The algebraic form of this equation,
relating to 3-dimensional (3D) diffusion of several fluores-
cent species through a gaussian volume, is
G  1 
1
Ni1
m
fi1  Di
11  S2 · Di
1⁄2
where fi is the fraction of species i, from a total number of
species m, with a mean dwell time in the volume of Di; N is
the number of fluorescent particles in the volume; and S is a
structure parameter, representing the ratio of the radial and
vertical axes 	1 and 	2, respectively, of the confocal volume.
For a species diffusing in 2 dimensions, such as a membrane
receptor, S ¡ 
, an algebraic form of the autocorrelation
equation simplifies to
G  1 
1
Ni1
m
fi1  Di
1
Nonlinear curve fitting of autocorrelation curves, using these
equations or combinations thereof to account for multiple 2D
and 3D diffusing components, yields values for N, fi, and Di
for each component. The confocal measurement volume VC
was then estimated as follows:
VC  
3⁄2 · 1 · 2
allowing the concentrations of each fluorescent species to be
calculated.
For FCS binding experiments, the number of particles N
and average dwell times D were calculated from autocorre-
lation curves that were generated at the upper membrane of
the CHO cells with fluorescent ligands. Autocorrelation
curves were fitted to a model containing one 3D component
(D1, representing free fluorescent ligand) and two 2D diffu-
sion components (D2 and D3, representing bound ligand),
in addition to a preexponential term to account for the triplet
state of the fluorophore. Binding was quantified by using the
value of N obtained from the fitted autocorrelation curve and
the appropriate contribution of the identified component
(D2 or D3). Total binding represents the sum of the D2 and
D3 components. The value for D1 was fixed during fitting to
that determined for free ligand in HBSS. For measurements
of the A3AR-GFP construct, results were fitted to a model
including two 2D diffusion components (32).
Calibration of the system allowed quantification of diffu-
sion coefficients and the number of particles, as described in
Results. The radius of the detection volume at the beam waist
(	1) was calculated by determining the mean dwell times of
aqueous solutions of rhodamine 6G (Rh6G) for the 488 nm
laser and of Cy5 NHS ester for the 633 nm laser, as follows:
1  4 · D · D1⁄2
where D is 3.16  106 cm2/s for Cy5 and 2.80  106 cm2/s
for Rh6G. Average 	1 values were 0.16 and 0.27 m for the
488 and 633 nm beam paths, respectively. These values were
subsequently used to calculate beam area at the waist (A 
 · 	1
2) and the particle density (N/m2) for each fluores-
cent component. To account for differences in the size of
confocal volumes generated using the 488 and 633 nm lasers,
average D values were converted to diffusion coefficient D
(m2/s) values, with the equation D  	1
2/4 · D. The n
values quoted for the FCS experiments represent the number
of cells that were measured in 	3 independent experiments.
FCS determination of allosteric interactions
CHO-A3 cells were prepared for FCS as described above. After
a 10 min preincubation at 22°C with HBSS containing 5 nM
CA200645, the medium was removed from the well; after 1
wash with ligand-free HBSS, the medium was replaced with
HBSS containing either an allosteric (VUF 5455) or or-
thosteric [xanthine amine congener (XAC)] ligand at various
concentrations. Single, 40 s FCS measurements were taken at
2, 4, and 6 min after medium replacement, with z scans
performed between reads to ensure proper placement of the
confocal volume. The amount of bound fluorescent antago-
nist was determined at each time point by using the analysis
methods described above.
Statistics
Statistical significance was determined by either Student’s
unpaired t test or ANOVA with the post hoc Newman-Keuls or
Dunnett analysis. All data are presented as means  se.
Unless otherwise noted, values of n refer to the number of
separate experiments performed.
RESULTS
Validation of CA200645 as a fluorescent A3AR
antagonist
CA200645 has been reported to be a high-affinity
fluorescent antagonist for human A3AR and has been
used to label the A3AR in live cells (27). Figure 1 shows
the binding of this ligand (25 nM; 10 min at 22°C) to
CHO-K1 cells stably transfected with an A3AR-GFP
construct. Single equatorial confocal images revealed
membrane clearly labeled with the red ligand that was
colocalized with the GFP fluorescence of the receptor
(Fig. 1). The observed membrane binding was substan-
tially reduced by preincubation with MRS 1220 (100
nM, 30 min at 22°C; Fig. 1), indicating that most of the
membrane-localized ligand could be attributed to spe-
cific binding to A3AR-GFP. Notably, the data obtained
at temperatures normally used for FCS (22°C) were
similar to those previously reported at 37°C (27).
FCS analysis of GFP-tagged human A3ARs
The biophysical properties of GFP-tagged A3ARs (in
stably transfected CHO-K1 cells) were investigated with
FCS by positioning the confocal volume on the cell
membrane directly above the nucleus (Fig. 2A). Auto-
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correlation analysis of the fluorescence fluctuations
(Fig. 2B) revealed 2 fluorescent species with dwell times
of 147  22 s and 80.1  6.4 ms (3 individual
experiments, n64 cells total). As described previously
(23), the first dwell time represents fluctuations gener-
ated by intramolecular photophysical effects, such as
blinking of the GFP fluorophore, while the second
represents the average dwell time of GFP-tagged A3ARs
in the confocal volume, yielding a diffusion coefficient
of 0.105  0.006 m2/s (Fig. 2C).
FCS analysis of CA200645 binding
FCS was then used to quantify the binding of CA200645
to the A3AR and the diffusional characteristics of
ligand–receptor complexes in nonspecified membrane
microdomains of transfected CHO-K1 cells. Autocorre-
lation analysis of FCS data generated by positioning the
confocal volume in an aqueous solution of CA200645
(100 nM) generated monophasic autocorrelation curves
(Fig. 3B, bottom left panel) consisting of a single
component (D1) with an average diffusion coefficient
of 257.7  8.9 m2/s (n6). To determine the diffu-
sional characteristics of CA200645/A3AR complexes in
live cells, we performed an intensity scan to enable
positioning of the confocal volume at the upper mem-
brane/extracellular boundary (Fig. 3A), which enabled
simultaneous detection of free antagonist and antago-
nist–receptor complexes. The autocorrelation curves
that resulted from FCS measurements at the upper
membrane after incubation of CHO-A3 cells with 10 nM
CA200645 (10 min at 22°C) yielded 2 additional, more
slowly diffusing, species (Fig. 3B, bottom right panel).
These 2 slowly diffusing species, D2 and D3, exhibited
average diffusion coefficients of 2.29 0.35 and 0.09
0.03 m2/s, respectively (n100 cells, 3 separate exper-
iments). Incubation with increasing concentrations of
CA200645 elevated the number of both species de-
tected on 0.2 m2 of membrane (Fig. 3C). It was
notable that the number of particles with D3 diffu-
sional characteristics appeared to saturate over the
concentration range used, whereas those for D2 con-
tinued to increase.
Figure 1. Live-cell confocal imaging of CA200645
binding. CHO-K1 cells stably expressing an
A3AR-GFP construct (green channel) were in-
cubated with the fluorescent A3AR antagonist
CA200645 (25 nM; red channel) for 10 min at
22°C (top panels). Cells that were preincubated
with the unlabeled A3AR antagonist MRS 1220
for 30 min at 37°C before addition of CA200645
exhibited reduced membrane binding of the
fluorescent ligand on A3AR-GFP-expressing
cells (bottom panels). Images are from an indi-
vidual experiment representative of 3 performed.
Figure 2. FCS analysis of A3AR-GFP-transfected CHO-K1 cells. A) Live-cell fluorescence images were used to localize the confocal
volume in the x–y plane above the nuclei of A3AR-GFP-expressing CHO-K1 cells (indicated by white cross). Scale bar  5 m.
B, C) The confocal volume was positioned directly on the cell membrane with a z scan, and fluctuations in fluorescence intensity
were measured (B) and subjected to autocorrelation analysis (C). Fitting of the autocorrelation curve was performed with a
model incorporating two 2D components. This analysis revealed 2 fluorescent species with dwell times of 147 22 s and 80.1
6.4 ms. As described previously (23), the first represents photophysical effects; the second represents the average dwell time of
GFP-tagged A3ARs in the confocal volume. Results in A and B are from 1 cell representative of 64 individual cells measured in
3 independent experiments used to derive the average dwell time (expressed as meanse).
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Competitive binding analysis
To further probe the pharmacological properties of
CA200645/A3AR complexes, we performed competi-
tive binding experiments with CA200645 (5 nM) and
unlabeled agonists and antagonists. Quantification of
the observed number of particles on the membranes of
cells that were preincubated with increasing concentra-
tions of the unlabeled, A3AR-selective antagonist MRS
1220 (Fig. 4A) revealed a reduction in the number of
slow-diffusing complexes (D3), whereas no significant
difference in the number of faster diffusing (D2)
complexes was observed. The pIC50 obtained for MRS
1220 from this analysis was 8.5 (Fig. 4A), giving an
estimate for pKi of 9.0 (following a Cheng-Prussoff
correction using a pKb for CA200645 of 8.5 ref. 27),
which is close to the value of 9.3 reported for this A3AR
antagonist (14). However, in contrast with our findings
using the fluorescent A3AR agonist ABEA-X-BY630 un-
der the same conditions (14), preincubation with the
nonselective adenosine receptor agonist NECA did not
result in a significant reduction in the number of slow
(D3)- or fast (D2)-diffusing complexes detected (Fig.
4B). These data suggest that using a fluorescent antag-
onist ligand under these conditions labels a species with
much lower affinity for agonists than when a fluores-
cent agonist ligand is used.
Quantification of allosteric interactions by FCS
In other studies, we showed, with the use of confocal
microscopy, that both allosteric ligands (e.g., VUF 5455;
ref. 35) and orthosteric ligands (e.g., XAC) can en-
hance the dissociation of a fluorescent agonist from
whole cells (29, 30). The latter finding provides evi-
dence of negative cooperativity across the interface of
A3AR homodimers (30). We therefore investigated
whether a similar finding could be demonstrated at a
subcellular level, by quantifying the 2 slowly diffusing
species detected by FCS with a fluorescent antagonist
(CA200645). To this end, a series of experiments was
performed in which medium was removed from the
cells and, after fluorescent ligand was washed out by
HBSS exchange, was replaced with HBSS, with or
without various concentrations of the A3AR allosteric
modulator VUF 5455. After the confocal volume was
positioned at the upper membrane with an intensity
scan, FCS measurements were taken at 2, 4, and 6 min
after fluorescent ligand washout. A reduction in the
number of slow-diffusing (D3) antagonist–receptor
complexes occurred over time in the presence of VUF
5455, further supporting the idea that this component
represents CA200645-A3AR complexes (Fig. 5A). This
effect was more pronounced at higher concentrations
of the allosteric modulator. Interestingly, in parallel
Figure 3. FCS analysis of CA200645
binding to the upper membrane
of CHO-A3 cells. A) To analyze
binding of the fluorescent an-
tagonist CA200645 to CHO-A3
cells, the confocal volume was
localized in the x–y plane with a
live transmitted light image and
subsequently positioned 0.5 m
above the peak intensity on the
upper membrane by using a flu-
orescence intensity z scan. B)
Fluorescence fluctuations (top
panels) and their associated au-
tocorrelation curves from mea-
surements of 100 nM CA200645
in HBSS (bottom left panel) and
on the upper membrane of a
CHO-A3 cell incubated with 5
nM CA200645 for 10 min at
22°C (bottom right panel). Au-
tocorrelation analysis of the
curve for CA200645 in solution
was best fit with a single 3D
component curve giving a dwell
time, D1, of 71 s. Similar anal-
ysis of the autocorrelation curve
from CHO-A3 cell membranes
revealed 2 further slow-diffusing
components (D2 and D3) of 4.8
and 48.6 ms. C) CHO-A3 cells
were incubated with the indi-
cated concentrations of CA200645 (10 min at 22°C), and FCS measurements were taken on the upper membrane as in panel
A. Autocorrelation analysis was performed as in panel B, to quantify the number of CA200645 particles exhibiting characteristics
of D2 (solid bars) and D3 (open bars), and total binding (D2D3; shaded bars) was determined as described in Materials and
Methods. Results are shown as means  se of 28 cells measured over 3 separate experiments. Average dwell times of the D2 and
D3 components were 8.7  1.3 and 265.8  41.7 ms, respectively.
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with the decrease in the number of D3 particles, there
was a corresponding increase in the number of faster-
diffusing D2 particles (Fig. 5B). This finding may
indicate that D2 represents A3AR complexes that have
released CA200645 during their time in the confocal
volume, as such particles appeared to have a shorter
apparent dwell time. It is also notable that the D2
component detected during washout in the absence of
added ligand (Figs. 5 and 6) was lower than when there
was no washout (Fig. 3), which suggests that rebinding
of CA200645 also contributes to the observation of the
D2 component in the presence of a fluorescent antag-
onist (see Discussion).
A similar time- and concentration-dependent de-
Figure 4. Effect of MRS 1220 and NECA on the formation of antagonist–A3AR complexes in the membranes of CHO-A3 cells.
A) CHO-A3 cells were incubated with the indicated concentrations of MRS 1220 (20 min at 37°C) before the addition of 5 nM
CA200645 (10 min at 22°C). FCS measurements were taken on the cell membrane, and D2, D3, and total bound CA200645
(D2D3) were quantified as described in Materials and Methods. B) Similar measurements were made using CHO-A3 cells
incubated with the indicated concentrations of NECA (10 min at 22°C) before the addition of 5 nM CA200645 (10 min at 22°C).
Results represent means  se of 30–32 individual cells taken over 4 independent experiments; analyzed by 1-way ANOVA and
the post hoc Newman-Keuls test. *P  0.05, **P  0.001 vs. HBSS-only control.
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Figure 5. Effect of the allosteric
ligand VUF 5455 on the number
of CA200645-A3AR complexes, by
FCS analysis. After a 20 min incu-
bation with 5 nM CA200645 (10
min at 22°C), CHO-A3 cells were
washed once with HBSS before
the medium was replaced with
HBSS, with or without the indi-
cated concentrations of the
A3AR allosteric ligand VUF
5455. FCS measurements were
taken on the cell membrane at
2, 4, and 6 min after washout,
and subsequent autocorrelation
analysis of fluorescence fluctua-
tions allowed quantification of
particles with characteristics of
D3 (A) and D2 (B), as described
in Materials and Methods, along
with their diffusion coefficients
(C and D, respectively). Results
represent means  se of 38–40
individual cells taken over 5 inde-
pendent experiments, analyzed
by 1-way ANOVA and the post hoc
Dunnett multiple-comparison test.
*P  0.05, **P  0.001, ***P 
0.0001 vs. HBSS-only control.
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crease in particles with D3 characteristics and a corre-
sponding increase in those with D2 was observed when
the orthosteric adenosine receptor antagonist XAC was
used (Fig. 6A, B), consistent with A3ARs existing as
dimers on CHO-K1 cell membranes, as we observed
earlier (30). Interestingly, there was no major change
in the diffusion coefficients for D3 and D2 during
washout in the presence or absence of VUF 5455 or
XAC (Figs. 5 and 6). The increased variability detected
in the HBSS control for D2 is probably accounted for
by the low number of particles detected of this compo-
nent, causing a decrease in signal-to-background ratio
and a more variable fit of this particular component
(Figs. 5D and 6D). It is also notable that the pIC50 values
obtained for XAC from inhibition of the number of D3
particles and the pEC50 for XAC-induced increase in
the number of D2 particles (both 6.0) are consistent
with the value obtained previously for the IC50 for XAC
binding to a fluorescent agonist–occupied A3AR (30).
Comparison of the properties of agonist and
antagonist receptor complexes
Initial observations showed that only a single diffusing
species was detected when diffusion of A3AR-GFP was
measured and that its diffusion coefficient was equiva-
lent to the D3 component detected when the CA200645-
A3AR complexes were measured, in agreement with our
findings when using the fluorescent agonist ABEA-X-
BY630 (14). These observations are consistent with the
hypothesis that D3 represents diffusion of ligand-A3AR
complexes, whereas D2 represents complexes in which
there is dissociation of the fluorescent ligand from the
A3AR during its transit through the confocal volume.
However, under equilibrium conditions, where the free
ligand is still present, this phenomenon may also reflect
ligand association with the receptor during its time in the
measurement volume. In the case of the washout experi-
ments with CA200645, the dissociation of the ligand was
sufficiently slow (Fig. 5) to allow the contribution of
ligand association to D2 to be largely discounted. These
data therefore suggest that D3 largely reflects the ligand-
occupied A3AR for both fluorescent agonists and antago-
nists. If this is the case, then a comparison of the number
of particles possessing D3 characteristics for each fluores-
cent ligand with the number of particles obtained for
A3AR-GFP within the same experiment should allow the
receptor occupancy to be calculated.
To determine the relative occupancy levels of
CA200645 and the previously described A3AR agonist,
ABEA-X-BY630, we performed autocorrelation analysis
to determine the number of receptor–ligand com-
plexes (D3 component) for both compounds relative
to the total number of A3AR-GFP receptors in trans-
fected CHO-K1 cells (10314/m2; n31). Our anal-
ysis revealed that the receptor occupancy levels for the
two compounds at the concentration used in the two
studies were not significantly different, at 24.5  2.7/
m2 (23.7%) and 21.8  1.6/m2 (21.0%) for ABEA-
X-BY630 and CA200645, respectively (n31–34; Fig. 7A);
however, the diffusion coefficients of ABEA-X-BY630-
A3AR complexes (0.240.02 m
2/s) were significantly
faster than those observed for the CA200645-A3AR
complexes in CHO-A3AR-GFP cells (0.160.04 m
2/s)
(Fig. 7B). The influence of agonists, antagonists, and
VUF 5455 on diffusional characteristics of GFP-tagged
40
30
20
10
0
15
10
5
0
0.3
0.2
0.1
0.0
6
4
2
0
Figure 6. Effect of the orthosteric
antagonist XAC on the number
of CA200645-A3AR complexes,
by FCS analysis. After a 20 min
incubation with 5 nM CA200645
(10 min, 22°C), CHO-A3 cells
were washed once with HBSS be-
fore the medium was replaced
with HBSS, with or without the
indicated concentrations of the
orthosteric adenosine receptor
antagonist XAC. FCS measure-
ments were taken on the cell
membrane at 2, 4, and 6 min
after washout, and subsequent
autocorrelation analysis of fluo-
rescence fluctuations allowed
quantification of particles with
characteristics of D3 (A) and D2
(B), as described in Materials and
Methods, along with their diffu-
sion coefficients (C and D, re-
spectively). Results represent
means  se of 30–32 individual
cells taken over 3 independent
experiments and analyzed by
2-way ANOVA and the post hoc
Dunnett test. *P  0.05, **P 
0.001, ***P  0.0001 vs. HBSS-
only control.
4217ANTAGONIST-OCCUPIED A3 RECEPTOR COMPLEXES
A3ARs was also investigated. However, the diffusion
coefficient of A3AR-GFP was not significantly affected
by treatment with NECA, MRS 1220, or VUF 5455 (Fig.
8B). It was notable, however, that there was a small but
significant (P0.05) increase in the number of parti-
cles with MRS 1220 and a significant (P0.01) decrease
in the number with VUF 5455 (Fig. 8A).
DISCUSSION
The technique of FCS provides a means by which the
pharmacological properties of receptor complexes
within discrete microdomains of the membrane of a
living cell can be interrogated in a quantitative manner
(31). FCS analysis of the membrane binding of the
fluorescent A3AR antagonist CA200645 in CHO-K1
cells expressing the human A3AR revealed 2 bound
diffusing components, D2 and D3, with diffusion coef-
ficients of 2.29  0.35 and 0.09  0.03 m2/s, respec-
tively. These were of similar magnitude, but not identi-
cal, to those that had been reported for the fluorescent
A3AR agonist ABEA-X-BY630 in the same cell line
(diffusion coefficients of 2.7 and 0.12 m2/s; ref. 14). It
was striking that analysis of the unoccupied GFP-la-
beled A3AR revealed only a single diffusing species with
a diffusion coefficient very similar to D3 detected with
CA200645. These data suggest that D3 represents dif-
fusion of the A3AR, although, as previously noted (14,
23), diffusion coefficients of this order are too slow to
represent a single receptor molecule and most likely
represent a larger oligomeric complex.
Consistent with the assignment of D3 to A3AR–
ligand complexes, the binding of CA200645 to this
complex could be potently antagonized by nanomolar
concentrations of A3AR antagonists such as MRS 1220.
This effect manifested as a significant reduction in the
number of individual fluorescently labeled (D3) diffus-
ing species detected within the confocal volume after
preincubation with unlabeled antagonists (Fig. 4). In
marked contrast, the binding of this low concentration
of CA200645 (5 nM) was insensitive to inhibition by the
agonist NECA at concentrations of up to 300 nM. These
data initially appear to be at odds with the data ob-
tained with the fluorescent agonist ABEA-X-BY630,
where D3 was exquisitely sensitive to low nanomolar
concentrations of NECA (14). However, this difference
most likely represents differential labeling of R and R*
states of the receptor by the low concentrations of
fluorescent agonist and antagonist used to achieve a
low number of particles for FCS experiments (14, 31).
It is worth pointing out that the concept of biased
Figure 8. FCS analysis of A3AR-GFP after treat-
ment with NECA, MRS 1220, or VUF 5455.
Number of particles (A) and diffusion coeffi-
cient (B) were obtained by fitting the autocor-
relation curve to a model incorporating two 2-D
components, the first representing the photo-
physical blinking effects of the GFP fluoro-
phore. Data shown for number of particles and
diffusion coefficient are for the second (D2)
component that represents the A3AR-GFP re-
ceptor. Cells were preincubated for 30 min with
300 nM or 10 M NECA, 1 M MRS 1220, or 10
M VUF 5455 at 37°C before FCS measure-
ments. Results represent means  se of 44–53
individual cells taken over 5 independent ex-
periments and analyzed by 1-way ANOVA with
the Dunnett multiple-comparison test. *P 
0.05; **P  0.01 vs. control values.
Figure 7. Comparison of the properties of A3AR-GFP and agonist–
and antagonist–A3AR complexes. FCS measurements of the A3AR-
GFP fusion were taken on the upper membrane of CHO-A3AR-
GFP cells by using 488 nm excitation (solid bars). Similarly, CHO-
A3AR-GFP cells were incubated with 5 nM ABEA-X-BY630 (shaded
bars) or 5 nM CA200645 (open bars), and FCS analysis of ligand–
receptor complexes on the upper cell membrane was used to
determine the number and diffusional characteristics of the
complexes. Number of particles (for D3; A) and diffusion coeffi-
cients (B), as determined from FCS measurements of ABEA-X-
BY630 and CA200645 D3 values and the equivalent slowly diffusing
GFP component, were compared. Component D2 was not always
detected in the experiments with ABEA-X-BY630 and CA200645,
but, in this situation, the diffusional characteristics were compatible
with D3 and are described as D3 in the figure. Results represent
means  se of 30–32 individual cells taken over 3 independent
experiments and analyzed by Student’s unpaired t test. *P  0.05,
**P  0.001 vs. HBSS-only control.
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agonism suggests that there is a plethora of R* confor-
mations (17).
Selective labeling of high-affinity agonist R* confor-
mations of GPCRs has been a characteristic of studies
with radiolabeled agonists (36–41) and is also true of
fluorescent ABEA-X-BY630 for the A3AR (14). In the
same manner, if an antagonist drug has a higher affinity
for R compared to R*, then it tends to selectively label
R if it is used at low concentrations (36–41). This
tendency is particularly the case for compounds that
exhibit inverse agonist properties (38–41). In the case
of CA200645, the occupancy achieved with the concen-
trations used in competition FCS experiments was of
the order of 21%, with little evidence of a component
with higher affinity for agonists. With ABEA-X-BY630
monitored in the same experiments, the occupancy
level was similar, but to a conformation that had high
affinity for nonfluorescent agonists (ref. 14 and Fig. 7).
These data suggest that CA200645 and ABEA-X-BY630
can be used to selectively label the R and R* forms,
respectively, by monitoring the D3-diffusing species of
the antagonist- or agonist-bound human A3AR. How-
ever, one consequence of this interpretation is that the
R and R* states cannot readily interconvert within the
timescale of these experiments. On the basis of classic
ternary complex receptor theory, one would predict
that agonist binding to R* would effectively reduce the
concentration of R for binding to CA200645 if the 2
conformations are in rapid equilibrium (41). This
notion suggests that there is a slow interconversion
between the 2 conformations or that there is compart-
mentalization of the R and R* complexes labeled by
CA200645 and ABEA-X-BY630.
We and others have shown that VUF 5455 is an
allosteric modulator of the A3AR (29, 35, 42). Further-
more, a study with a fluorescent analogue of adenosine
in single living cells has shown that VUF 5455 can
enhance the dissociation of the labeled ligand from the
A3AR in a manner consistent with its allosteric mecha-
nism of action (29). To determine whether a similar
phenomenon could be demonstrated in discrete mem-
brane microdomains using FCS, we undertook a similar
experimental strategy using CA200645 as the labeled
ligand. Within the limits of the experimental setup for
the FCS studies, CA200645 was shown to dissociate
slowly from the A3AR (monitored as D3) with negligi-
ble dissociation of ligand occurring within 6 min of
removal of CA200645. However, in the presence of
increasing concentrations of VUF 5455 during the
washout phase of the experiment, there was a marked
and concentration-dependent enhancement of the dis-
sociation kinetics of CA200645, consistent with the data
obtained in whole cells (29).
It is clear that, in addition to D3, there is a secondary
diffusing species, D2, that is detected for both fluores-
cent A3AR agonists (14) and antagonists (current
study), but not when the unoccupied receptor is mon-
itored (using the A3AR-GFP fusion). In the current
study, the insensitivity of the D2 component of
CA200645 binding to inhibition by both agonists and
antagonists initially suggested that it represents a non-
specific binding component. However, the dissociation
experiments undertaken with the allosteric modulator
VUF 5455 revealed a significant change in the number
of particles detected with a diffusion coefficient com-
patible with D2. The simplest explanation of these data
is that they represent a diffusional component artifi-
cially generated by the dissociation of fluorescent li-
gand from the receptor species during its transit
through the confocal volume (Fig. 9). The slow disso-
ciation of CA200645 from the A3AR in the absence of
the allosteric modulator and the low number of parti-
Figure 9. Representation of the ways in which differences in
diffusion coefficients (D values) may be generated for A3AR-
GFP and fluorescent ligand-occupied A3AR complexes. Pink
area represents the confocal volume; blue area at the waist is
a representation of the cell membrane within the volume. A)
If the ligand stays bound to the receptor while it is present in
the confocal volume, then the A3AR-GFP and A3AR–ligand
complexes will have the same diffusion coefficients. B) If the
fluorescent ligand associates with, or dissociates from, the
receptor during its time in the measurement volume, then
the FCS analysis will conclude that the A3AR–ligand complex
was present for a shorter time, and a faster diffusion coeffi-
cient will be calculated compared to that obtained for A3AR-
GFP complexes. C, D) Scenarios for a ligand dissociation
experiment where the receptor is prelabeled with fluorescent
ligand, and during the washout phase, the ligand dissociates
during transit through the volume under control conditions
(C) or after the addition of an allosteric regulator (D). In the
experiments shown in Figs. 5 and 6, there is a decrease in the
number of particles showing the characteristics of panel C
and an increase in the number of particles showing the
characteristics of panel D. Calculation of the diffusion coeffi-
cient is necessary to compare the average dwell times of
fluorescent species within the confocal volume because of the
different sizes of confocal volume illuminated by different
laser wavelengths when focused on a diffraction-limited point
(such as was used in the FCS experiments). However, for the
purposes of this illustration, we assumed that the confocal
volumes were the same for the red- and green-labeled species.
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cles with D2 diffusional characteristics are consistent
with this interpretation.
If this hypothesis is correct, then FCS analysis pro-
vides a very powerful approach to monitor ligand-
binding kinetics in real time and within discrete mem-
brane microdomains of single living cells. Under
equilibrium conditions, it is possible that D2 represents
the extent of transient ligand dissociation or, alterna-
tively, association during transit of the receptor
through the confocal volume (Fig. 9B). The likelihood
of the respective contribution of ligand dissociation or
association to this fast-diffusing component is dictated
by both experimental design (i.e., whether data are
collected immediately after addition of fluorescent
ligand or after ligand washout) and the binding kinet-
ics of the fluorescent ligand. In competition experi-
ments, however, the sensitivity of D2 to inhibition by
preincubation with nonfluorescent ligands provides
some insight into the contribution of fluorescent ligand
association to this FCS component. In the case of
CA200645, the insensitivity of D2 to preincubation with
nonfluorescent A3AR ligands suggests that fluorescent
ligand association is not a major contributor to the D2
component for this ligand. Furthermore, the slow
dissociation kinetics of CA200645 (ref. 27 and Fig. 5)
make it particularly amenable to the study of unlabeled
ligands (e.g., allosteric modulators) that increase ligand
dissociation.
To test this concept further, we investigated the
effect on D2 of applying an orthosteric ligand during
the washout of CA200645. We showed in earlier work
that the A3AR exists in homodimeric complexes in
CHO cells expressing the human A3AR. In addition, we
showed in the same study that negatively cooperative
interactions exist between the orthosteric binding sites
of individual protomers (30). This finding was demon-
strated by the ability of orthosteric ligands (adenosine,
XAC, and NECA) to enhance the dissociation kinetics
of a fluorescent agonist from the A3AR (28). Further-
more, this effect was reduced by the increased expres-
sion of a ligand-binding–deficient mutant A3AR (to
increase the proportion of homodimers containing a
protomer that is devoid of binding capacity; ref. 30). In
the current study, addition of XAC after washout of
CA200645 resulted in a marked decrease in the num-
ber of particles represented by D3 and a parallel
increase in the number of particles exhibiting the
diffusional characteristics of D2. These results are
consistent with negative cooperativity interactions
across the A3AR dimer interface and provide further
evidence that the D2 component in this experimental
paradigm is indicative of A3AR complexes that have
released the fluorescent ligand during residence in the
FCS confocal volume.
These data suggest that the presence and character-
istics of the D2 component of the observed ligand
A3AR–diffusing species provides important informa-
tion on the average residence time of fluorescent
ligand on the receptor, provided that the observed D2
is substantially lower than the average time that the
receptor spends within the confocal volume (i.e., the
FCS dwell time determined using GFP-tagged A3ARs).
This general concept can be further expanded to
explain the small differences in diffusion coefficients
for A3-GFP, CA200645 (D3), and ABEA-X-BY630 (D3)
when measured in the same cells (Fig. 7). The simplest
explanation of the different diffusion coefficients ob-
tained with fluorescent ligand compared to the mobil-
ity of the simultaneously measured GFP-labeled A3AR is
that they reflect that the life of the ligand–receptor
complex is shorter (i.e., dissociation of ligand from the
receptor is quicker) than the average dwell time of the
A3AR in the confocal volume. On this basis, these data
indicate that ABEA-X-BY630 dissociates from the A3AR
far quicker than CA200645, which is consistent with
previous observations (14, 27). The data also suggest
that the average residence times of ABEA-X-BY630 and
CA200645 on the A3AR may be reported by D3 under
control conditions when this component has a faster
diffusion coefficient (i.e., shorter dwell time in the
measurement volume) than that of the A3AR-GFP
species. Diffusion coefficients must be used to compare
the diffusion of red- and green-labeled species in these
examples, because the measurement volumes illumi-
nated by 633 nm (red) light is inherently larger than
that illuminated by 488 nm (green) laser light. These
observations suggest that the actual dwell time (D3)
determined for CA200645 in control conditions repre-
sents the average residence time of CA200645 on the
receptor, whereas the D2 levels determined after a 6
min treatment with VUF 5455 or XAC represent allos-
terically regulated ligand residency times for CA200645. The
predicted residence times of these 2 components are
presented in Table 1. As would be expected in the case
of allosteric regulation, the average CA200645 resi-
dence time was substantially reduced in the presence of
the allosteric regulator VUF 5455 or XAC during
fluorescent ligand dissociation (Figs. 5 and 6). It is also
TABLE 1. Predicted average receptor residence times for CA200645 in the absence and presence of
ligands that allosterically regulate the A3AR
Experiment HBSS (ms) VUF 5455 (ms) XAC (ms)
1 249.2  34.9 19.3  14.3
2 228.1  68.0 18.0  22.1
Data were taken from the apparent dwell times for A3AR/CA200645 complexes in the confocal
volume measured by FCS analysis in the experiments described in Figs. 5 and 6, from which the diffusion
coefficients were calculated (see Materials and Methods). HBSS values were taken from the D3
component of the measurements made in HBSS medium after a 6 min washout in the presence of HBSS.
VUF 5455 and XAC data were taken from the D2 component of the measurements made after a 6
min washout in the presence of 10 M VUF 5455 (Fig. 5) or 10 M XAC (Fig. 6). See Figs. 5 and 6 for
further experimental details.
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important to remember that, because of the low con-
centrations of CA200645 used in these FCS experi-
ments (5 nM), this allosteric effect is being monitored
at the inactive R state of the receptor.
The calculation of actual receptor residence times is
usually technically difficult when classic binding tech-
niques are used, because of the high potential for
rebinding of labeled ligand to the receptor during
dissociation from the receptor (from the medium or
lipid biophase; refs. 43–45). In the FCS washout exper-
iments performed in this study, the predicted Koff rate
constant could be estimated for a simple ligand–recep-
tor interaction (where there is no interconversion
between R and R* within the timescale of the experi-
ment; see above) by taking the reciprocal of the mea-
sured dwell time (46). In this case, the dwell time can
be taken as the D2 component during dissociation of
the fluorescent ligand (where the A3AR is under allo-
steric regulation and the D2 values are much shorter
than the average dwell time of the A3AR in the confocal
volume), giving a Koff of 55.5/s for CA200645, which is
much faster than that determined in standard dissoci-
ation experiments that measure the residual level of
binding at different times in intact cells and membrane
fragments (e.g., 0.57/min for fluorescent adenosine at
the A3AR; ref. 30). One can imagine that although
ligand association on the receptor almost certainly
occurs, the FCS D2 dwell time shows the mean resi-
dence time on individual receptors. A similar analysis
can be undertaken for the D3 component, yielding a
Koff of 4.02/s, which should represent the off rate from
the A3AR when there is no allosteric regulation. How-
ever, this latter value should be used with caution, since
the dwell time (D3) for CA200645 under normal
conditions is close to that predicted for A3AR-GFP and
may not be sufficiently different to distinguish it with
confidence from the time spent by the A3AR in the
confocal volume. What is clear, however, is that alloste-
ric regulation has dramatically reduced the ligand
residence time on the A3AR, as we predicted (30).
The suggested interpretation of the nature of D2
raises the question of why there is a low level of this
component present when no nonfluorescent allosteric
regulator is present. One interpretation, however, is
consistent with this observation. Fig. 3C shows that
there was clearly an increase in the proportion of D2 as
the concentration of fluorescent CA200645 increased.
The demonstration of cooperativity across the A3AR
dimer interface as an enhanced dissociation of fluores-
cent ligand by a nonfluorescent orthosteric ligand (this
study and ref. 30) relies on the use of low concentra-
tions of the fluorescent probe to occupy only one of the
two interacting protomers. When higher concentra-
tions of fluorescent ligand are used, there is an in-
creased probability that both protomers will be occu-
pied by fluorescent ligand, inducing an allosterically
enhanced dissociation of fluorescent ligand (which will
manifest itself as an increased number of particles
demonstrating D2 diffusion times). The concentration-
dependent increase in the number of fluorescent spe-
cies showing D2 kinetics is consistent with this hypoth-
esis. In addition, it is clear from Fig. 6 that the decrease
in the number of D3 particles does not exactly match
the increase in the number of D2 particles as the
concentration of XAC present during the dissociation
phase of the experiment increases. It is likely that, even
at the low concentration of fluorescent ligand used in
this experiment, a few of the A3AR–antagonist com-
plexes will have both protomers occupied by fluores-
cent ligand (i.e., have double brightness). As a conse-
quence, dissociation of one of these may well have an
inordinate influence on the estimated number of D3
particles that is not exactly balanced by an increase in
the number of D2 particles.
In summary, the current study provides important
information on the pharmacological properties of flu-
orescent antagonist–occupied adenosine A3AR com-
plexes. The data obtained indicate that the inactive R
conformation of the receptor is selectively monitored
by FCS with a fluorescent antagonist ligand and that
important insights into ligand binding kinetics, ligand
residence time, allosterism, and receptor dimerization
can be deduced from careful analysis of the different
components of FCS data obtained in discrete mem-
brane domains of single living cells. In particular, the
study demonstrated that fluorescent ligand residence
times can be monitored by FCS and that these are
dramatically reduced by allosterism across the A3–AR
dimer interface.
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